During the past decade, JPS Center for Cancer Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JPS Center for Cancer Care" #1 sponsor was "Acrotech Biopharma Inc." with 1 trials, followed by "CTI BioPharma" with 1 trials sponsored, "East Valley Hematology and Oncology Medical Group" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Threshold Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JPS Center for Cancer Care" #1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Mena, Raul, M.D." with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Pharmatech Oncology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "JPS Center for Cancer Care" are "Chronic Lymphocytic Leukemia" (1 trials), "NSCLC" (1 trials), "Non-Small Cell Lung Cancer" (1 trials), "Pancreatic Cancer" (1 trials) and "Peripheral T-cell Lymphoma" (1 trials). Many other conditions were trialed in "JPS Center for Cancer Care" in a lesser frequency.

Most popular intervention types in "JPS Center for Cancer Care" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Glufosfamide" (1 trials), "Nipent, Cytoxan, Rituxan" (1 trials), "bevacizumab" (1 trials), "erlotinib HCl" (1 trials) and "paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "JPS Center for Cancer Care" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "JPS Center for Cancer Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in JPS Center for Cancer Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in JPS Center for Cancer Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".